Providing market intelligence for more than 35 years

In The News

Netflix Reports Lowest Churn As Fifth Of US Broadband Households Cancel OTT In 2015

According to research from Parks Associates, a fifth of broadband US households have cancelled at least one over-the-top (OTT) video service in the past 12 months, up two percentage points from a year ago.

Brett Sappington, senior director of research at Parks, said that Netflix is still the OTT leader in the US, with 52% of all US broadband households subscribing to the service at the end of 2015. Netflix also had the lowest churn rate as a percentage of its total subscriber base. In the past 12 months, just 5% of US broadband households cancelled their Netflix account, including those who cancelled at the end of the trial period. That figure represents 9% of the company’s current subscriber base.

From the articles "Netflix Reports Lowest Churn As Fifth Of US Broadband Households Cancel OTT In 2015" by Michelle Clancy.
 

Previously In The News

15 Percent of U.S. Broadband Households Plan to Buy Wireless Speakers

A recent Parks Research study found that, of U.S. broadband households, 18 percent plan to buy earbuds over the next 12 months, 16 percent plan to buy headphones, and 15 percent plan to buy wireless s...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...